Advertisement
Screener

ENVOY MEDICAL, INC. (COCH) Operating Income

ENVOY MEDICAL, INC. Operating Income

ENVOY MEDICAL, INC. (COCH) reported Operating Income of -$5.57 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.

Financial Statements › Income Statement

us-gaap:OperatingIncomeLoss · last filed 2026-08-10

  • ENVOY MEDICAL, INC. operating income (loss) for the quarter ending 2026-06-30 was -$5.57M.
  • ENVOY MEDICAL, INC. operating income (loss) for the quarter ending 2026-03-31 was -$5.96M.
  • ENVOY MEDICAL, INC. operating income (loss) for the quarter ending 2025-12-31 was -$6.38M.
  • ENVOY MEDICAL, INC. operating income (loss) for the quarter ending 2025-09-30 was -$5.71M.
  • ENVOY MEDICAL, INC. operating income (loss) for fiscal 2023 was -$18.36M.
  • ENVOY MEDICAL, INC. operating income (loss) for fiscal 2022 was -$8.71M.
  • ENVOY MEDICAL, INC. operating income (loss) for fiscal 2021 was -$5.20M.
Period endOperating Income (Loss) 0 monthOperating Income (Loss) 3 monthOperating Income (Loss) 3 month as first filedOperating Income (Loss) 6 monthOperating Income (Loss) 6 month as first filedOperating Income (Loss) 9 monthOperating Income (Loss) 9 month as first filedOperating Income (Loss) 12 monthOperating Income (Loss) 12 month as first filed
2026-06-30-$5.57M
10-Q · filed 2026-08-10
-$11.53M
10-Q · filed 2026-08-10
-$17.91M
derived: sum of 3 quarters · filed 2026-08-10
-$23.62M
derived: sum of 4 quarters · filed 2026-08-10
2026-03-31-$5.96M
POS AM · filed 2026-06-12
-$12.34M
derived: sum of 2 quarters · filed 2026-06-12
-$18.05M
derived: sum of 3 quarters · filed 2026-06-12
-$23.12M
derived: sum of 4 quarters · filed 2026-08-10
2025-12-31-$6.38M
derived: POS AM 12 month − 10-Q 9 month · filed 2026-06-12
-$12.09M
derived: sum of 2 quarters · filed 2026-06-12
-$17.16M
derived: sum of 3 quarters · filed 2026-08-10
-$22.27M
POS AM · filed 2026-06-12
2025-09-30-$5.71M
10-Q · filed 2025-11-10
-$10.78M
derived: sum of 2 quarters · filed 2026-08-10
-$15.88M
10-Q · filed 2025-11-10
-$20.43M
derived: sum of 4 quarters · filed 2026-08-10
2025-06-30-$5.07M
10-Q · filed 2026-08-10
-$10.18M
10-Q · filed 2026-08-10
-$14.73M
derived: sum of 3 quarters · filed 2026-08-10
-$19.70M
derived: sum of 4 quarters · filed 2026-08-10
2025-03-31-$5.11M
POS AM · filed 2026-06-12
-$9.66M
derived: sum of 2 quarters · filed 2026-06-12
-$14.63M
derived: sum of 3 quarters · filed 2026-06-12
-$19.48M
derived: sum of 4 quarters · filed 2026-06-12
2024-12-31-$4.55M
derived: POS AM 12 month − 10-Q 9 month · filed 2026-06-12
-$9.52M
derived: sum of 2 quarters · filed 2026-06-12
-$14.37M
derived: sum of 3 quarters · filed 2026-06-12
-$19.26M
POS AM · filed 2026-06-12
2024-09-30-$4.97M
10-Q · filed 2025-11-10
-$4.97M
10-Q · filed 2024-11-14
-$9.82M
derived: sum of 2 quarters · filed 2025-11-10
-$14.71M
10-Q · filed 2025-11-10
-$14.73M
10-Q · filed 2024-11-14
-$21.43M
derived: sum of 4 quarters · filed 2025-11-10
2024-06-30-$4.85M
10-Q · filed 2025-07-31
-$4.86M
10-Q · filed 2024-08-12
-$9.73M
10-Q · filed 2025-07-31
-$9.76M
10-Q · filed 2024-08-12
-$16.46M
derived: sum of 3 quarters · filed 2025-07-31
-$19.84M
derived: sum of 4 quarters · filed 2025-07-31
2024-03-31-$4.88M
10-Q · filed 2025-05-01
-$4.90M
10-Q · filed 2024-05-15
-$11.61M
derived: sum of 2 quarters · filed 2025-05-01
-$14.99M
derived: sum of 3 quarters · filed 2025-05-01
-$19.47M
derived: sum of 4 quarters · filed 2025-05-01
2023-12-31-$6.72M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31
-$10.11M
derived: sum of 2 quarters · filed 2025-03-31
-$14.59M
derived: sum of 3 quarters · filed 2025-03-31
-$18.36M
10-K · filed 2025-03-31
-$18.37M
10-K · filed 2024-04-01
2023-09-30-$3.38M
10-Q · filed 2024-11-14
-$7.87M
derived: sum of 2 quarters · filed 2024-11-14
-$11.64M
10-Q · filed 2024-11-14
-$14.54M
derived: sum of 4 quarters · filed 2024-11-14
2023-06-30-$4.48M
10-Q · filed 2024-08-12
-$98.60K
10-Q · filed 2023-08-14
-$8.25M
10-Q · filed 2024-08-12
-$2.59M
10-Q · filed 2023-08-14
-$11.16M
derived: sum of 3 quarters · filed 2024-08-12
-$12.95M
derived: sum of 4 quarters · filed 2024-08-12
2023-03-31-$3.77M
10-Q · filed 2024-05-15
-$2.49M
10-Q · filed 2023-05-15
-$6.68M
derived: sum of 2 quarters · filed 2024-05-15
-$8.47M
derived: sum of 3 quarters · filed 2024-05-15
-$9.37M
derived: sum of 4 quarters · filed 2024-05-15
2022-12-31-$2.91M
derived: 10-K 12 month − 10-Q/A 9 month · filed 2024-04-01
-$4.70M
derived: sum of 2 quarters · filed 2024-04-01
-$5.60M
derived: sum of 3 quarters · filed 2024-04-01
-$8.71M
10-K · filed 2024-04-01
-$4.89M
10-K · filed 2023-04-03
2022-09-30-$1.80M
10-Q/A · filed 2024-01-17
-$1.03M
10-Q · filed 2022-11-14
-$2.70M
derived: sum of 2 quarters · filed 2024-01-17
-$5.80M
10-Q/A · filed 2024-01-17
-$3.42M
10-Q · filed 2022-11-14
-$5.15M
derived: sum of 4 quarters · filed 2024-01-17
2022-06-30-$901.36K
10-Q · filed 2023-08-14
-$2.39M
10-Q · filed 2023-08-14
-$3.35M
derived: sum of 3 quarters · filed 2023-08-14
-$6.34M
derived: sum of 4 quarters · filed 2023-08-14
2022-03-31-$1.49M
10-Q · filed 2023-05-15
-$2.45M
derived: sum of 2 quarters · filed 2023-05-15
-$5.44M
derived: sum of 3 quarters · filed 2023-05-15
-$6.51M
derived: sum of 4 quarters · filed 2023-05-15
2021-12-31-$963.90K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-03
-$3.95M
derived: sum of 2 quarters · filed 2023-04-03
-$5.02M
derived: sum of 3 quarters · filed 2023-04-03
-$5.20M
10-K · filed 2023-04-03
2021-09-30-$2.99M
10-Q · filed 2022-11-14
-$4.06M
derived: sum of 2 quarters · filed 2022-11-14
-$4.24M
10-Q · filed 2022-11-14
2021-06-30-$1.07M
10-Q · filed 2022-08-15
-$1.25M
10-Q · filed 2022-08-15
2021-03-31-$966.28K
10-Q · filed 2022-05-16
2020-12-31-$701.00
10-K · filed 2022-03-31

Similar stocks

Stock NameCountryMarket CapPE Ratio
ALPHA PRO TECH LTD (APT)$0.052B13.63
MYOMO, INC. (MYO)United States$0.065B-2.85
MILESTONE SCIENTIFIC INC. (MLSS)United States$0.036B-6.85
Safe Pro Group Inc. (SPAI)United States$0.090B
Lifeward Ltd. (LFWD)$0.021B
ENvue Medical, Inc. (FEED)United States$0.011B
LAKELAND INDUSTRIES INC (LAKE)United States$0.104B-4.21
NutriBand Inc. (NTRB)United States$0.109B
Bone Biologics Corp (BBLG)United States$0.001B
Conexeu Sciences Inc. (CNXU)United States$0.111B